This Cannabis Stock Has Huge Potential

Our first foray into the world of medical and recreational cannabis over at Fast-Track Millionaire remains the industry leader.

It was the first among the industry players to secure a large and lucrative partnership deal — in the form of a multi-billion-dollar link with a well-known maker of beers, wines and spirits.

It was also the first to buy a large U.S.-based competitor, although the deal is designed not to take place until the U.S. legalizes marijuana on a federal level.

In many ways, our first cannabis stock pick has set the standard in the budding industry. But other industry players have been following suit. And my Fast-Track Millionaire readers and I have been paying very close attention, looking for what could be tomorrow's household names in Big Cannabis.

Read the full article at Nasdaq.

Don’t Stop Here

More To Explore

AARD: 56% Drop Sparks Urgent Investor Scrutiny!

Overview: Aardvark Therapeutics, Inc. (Nasdaq: AARD) is a clinical-stage biotech focused on therapies for metabolic diseases and Prader-Willi Syndrome (PWS) – a rare genetic disorder

Gene-Editing Goldrush Meets AI and ETF Plays

Opening Recap Market Pulse: Gene-editing fervor rippled through biotech circles after a Mordor Intelligence report flagged double-digit growth in cell line development through 2031. Down

EOSE: Act Now! Deadline Approaches for Loss Recovery!

Introduction Eos Energy Enterprises, Inc. (NASDAQ: EOSE) is a battery technology company focused on zinc-based long-duration energy storage systems (investors.eose.com). The company went public via